Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot study of intramuscular hydrocortisone injection site and formulation during hypocortisolaemia
2015-001090-40Phase 4Unknown
- Sponsor
- The London Clinic
- Start
- Apr 2015
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of hydrocortisone sodium succinate and hydrocortisone in Addison's disease and hypoadrenocorticism (2 arms), sponsored by The London Clinic. Primary endpoints: Peak serum cortisol, Mean cortisol and 2 more. Status: unknown.
02
Drugs
hydrocortisone sodium succinatehydrocortisone
03
Conditions
Addison's diseasehypoadrenocorticism
Beyond the preview
Go deeper on 2015-001090-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-001090-40.